Medical Condition News

RSS

Scientists discover sleep switch in fruit fly's brain

Rather than count sheep, drink warm milk or listen to soothing music, many insomniacs probably wish for a switch they could flick to put themselves to sleep.

24 Jun 2011

Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer

CEL-SCI Corporation announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan.

24 Jun 2011

Researchers discover new mechanism for origin of Barrett's esophagus

Researchers have discovered a new mechanism for the origin of Barrett's esophagus, an intestine-like growth in the esophagus that is triggered by chronic acid reflux and often progresses to esophageal cancer.

24 Jun 2011

FDA grants Orphan Drug Designation for Accentia's Revimmune to treat two autoimmune diseases

Accentia Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Revimmune, the Company's proprietary system-of-care based on high-dose administration of Cytoxan, for the treatment of two autoimmune disease indications, systemic sclerosis and autoimmune hemolytic anemia.

24 Jun 2011

Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years

Allergan, Inc. today announced a new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases that found the cost of a gastric banding weight-loss surgery procedure, such as Allergan's LAP-BAND Adjustable Gastric Banding System, was offset by reductions in obesity-related medical costs within 2.25 years for surgery eligible patients with diabetes, and within four years of the procedure for all surgery eligible patients.

23 Jun 2011

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.

23 Jun 2011

Majority of cancers are due to epigenetic influences

Dr. Ajay Goel, Ph.D., Director of Epigenetics and Cancer Prevention at the Gastrointestinal Research Center at Baylor University Medical Center in Dallas, TX, has announced plans for a series of upcoming studies to continue to unlock the mechanisms by which curcumin prevents cancer via its influence on epigenetic activity.

23 Jun 2011

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today that their lead program, SBC-102, an enzyme replacement therapy for Lysosomal Acid Lipase (LAL) Deficiency, currently in clinical trials, has been granted fast track designation by the U.S. Food and Drug Administration (FDA).

23 Jun 2011

Spinal manipulative therapy provides minor but significant benefits for patients with chronic low back pain

Spinal manipulative therapy (SMT) has significant but very small benefits for patients with chronic low back pain, according to a special review article in the June 1 issue of Spine.

23 Jun 2011

New proteomics-based approach to analyze bone quality

A new technique developed at Rensselaer Polytechnic Institute allows researchers to collect large amounts of biochemical information from nanoscale bone samples.

23 Jun 2011

Resveratrol may make old age more tolerable, but not prevent it

A University of Florida review of research finds the polyphenol compound known as resveratrol found in red wine, grapes and other fruits may not prevent old age, but it might make it more tolerable.

23 Jun 2011

FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy

Repligen Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for RG3039, a potential treatment for Spinal Muscular Atrophy.

23 Jun 2011

MAP to present LEVADEX data on migraine at 15th Congress of IHC

MAP Pharmaceuticals, Inc. today announced that LEVADEX orally inhaled migraine drug will be featured in four poster presentations, including one late-breaker presentation, at the 15th Congress of the International Headache Society (IHC) in Berlin, Germany on June 23-26, 2011.

23 Jun 2011

Leicester free public lecture aims to reduce mortality from abdominal aortic aneurysms

A free public lecture by a University of Leicester academic on Tuesday, 28 June will discuss recent advances to reduce mortality from aortic aneurysms.

23 Jun 2011

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

A treatment that has virtually no side effects has been found to be an effective weapon for fighting early-stage breast cancer, according to results of a clinical trial conducted at Loma Linda University Medical Center.

23 Jun 2011

Fat substituted snack foods may contribute to weight gain

Fat substitutes used in popular snack foods to help people control weight may have the opposite effect, according to Purdue University research.

23 Jun 2011

FDA releases new tobacco warning labels that emphasize "horror factor"

The labels, which represent the first change in these warnings in 25 years, are required under a federal law that was passed in 2009 and must be displayed on cigarette packaging and advertisements by September 2012.

23 Jun 2011

Scientists study degradation of toxic compound found in groundwater systems

Vinyl chloride is a cancer-causing compound formed from solvents in groundwater systems under anaerobic conditions. These solvents are used in many industrial applications around the world and often belong to the most encountered groundwater pollutants in industrialized countries.

23 Jun 2011

Positive results from Neurelis NRL-1 Phase I pharmacokinetic study on acute repetitive seizures

In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam achieved positive clinical results in a Phase I pharmacokinetic study.

23 Jun 2011

Los Alamos National Lab scientists win three R&D Magazine's 2011 awards

Los Alamos National Laboratory scientists have won three of R&D Magazine's 2011 R&D100 Awards. Recognized as the "Oscars of Invention" by the Chicago Tribune, these awards honor the top 100 proven technological advances of the past year.

23 Jun 2011

Medical Condition News

Scientists discover sleep switch in fruit fly's brain

Orient Europharma to initiate CEL-SCI's Multikine Phase III trial in head and neck cancer

Researchers discover new mechanism for origin of Barrett's esophagus

FDA grants Orphan Drug Designation for Accentia's Revimmune to treat two autoimmune diseases

Reductions in obesity-related medical costs offset cost of gastric banding surgery within 2.25 years

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Majority of cancers are due to epigenetic influences

FDA grants fast track designation to Synageva for SBC-102 program for Lysosomal Acid Lipase Deficiency

Spinal manipulative therapy provides minor but significant benefits for patients with chronic low back pain

New proteomics-based approach to analyze bone quality

Resveratrol may make old age more tolerable, but not prevent it

FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy

MAP to present LEVADEX data on migraine at 15th Congress of IHC

Leicester free public lecture aims to reduce mortality from abdominal aortic aneurysms

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

Fat substituted snack foods may contribute to weight gain

FDA releases new tobacco warning labels that emphasize "horror factor"

Scientists study degradation of toxic compound found in groundwater systems

Positive results from Neurelis NRL-1 Phase I pharmacokinetic study on acute repetitive seizures

Los Alamos National Lab scientists win three R&D Magazine's 2011 awards

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News